Status: COMPLETE
Trefoil completed the INTREPID clinical trial – a Phase 1/2 Study of THX1114(NM141).
Read the press release here.
Have Other Questions?
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.